In AML mouse models, leukemia antigen presentation by immature antigen-presenting cells or splenic CD8a+ dendritic cells (DCs) have respectively induced deletional T cell tolerance and CD8+ T cell tolerance [37,38]. The gene discussed is CD8A; the disease is leukemia.